ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	5/110	106/8144	0.01414	0.9174	0.9174	SLC34A3/SLC34A1/GNA13/RXRA/MEF2C	5
KEGG	hsa03320	PPAR signaling pathway	4/110	75/8144	0.01839	0.9174	0.9174	PCK1/FABP4/RXRA/OLR1	4
KEGG	hsa04371	Apelin signaling pathway	5/110	139/8144	0.0397	0.9174	0.9174	PIK3R5/CALML5/MAP1LC3C/GNA13/MEF2C	5
KEGG	hsa05418	Fluid shear stress and atherosclerosis	5/110	139/8144	0.0397	0.9174	0.9174	CALML5/MIR10A/KEAP1/NFE2L2/MEF2C	5
KEGG	hsa04060	Cytokine-cytokine receptor interaction	8/110	295/8144	0.04579	0.9174	0.9174	CCL8/IFNE/CTF1/CSH2/IL15/IL7R/CCR5/CCL13	8
KEGG	hsa04744	Phototransduction	2/110	29/8144	0.05794	0.9174	0.9174	GNAT2/CALML5	2
KEGG	hsa04630	JAK-STAT signaling pathway	5/110	162/8144	0.06795	0.9174	0.9174	IFNE/CTF1/CSH2/IL15/IL7R	5
KEGG	hsa04022	cGMP-PKG signaling pathway	5/110	167/8144	0.07526	0.9174	0.9174	PIK3R5/CALML5/INS/GNA13/MEF2C	5
KEGG	hsa05143	African trypanosomiasis	2/110	37/8144	0.08873	0.9174	0.9174	IDO1/IDO2	2
KEGG	hsa04068	FoxO signaling pathway	4/110	131/8144	0.1009	0.9174	0.9174	IL7R/INS/PCK1/NLK	4
KEGG	hsa04142	Lysosome	4/110	132/8144	0.1031	0.9174	0.9174	ACP5/PLA2G15/AP3S1/ATP6V1H	4
KEGG	hsa04610	Complement and coagulation cascades	3/110	85/8144	0.1073	0.9174	0.9174	SERPING1/CFB/A2M	3
KEGG	hsa00380	Tryptophan metabolism	2/110	42/8144	0.1099	0.9174	0.9174	IDO1/IDO2	2
KEGG	hsa04910	Insulin signaling pathway	4/110	137/8144	0.114	0.9174	0.9174	CALML5/INS/PCK1/RAPGEF1	4
KEGG	hsa04062	Chemokine signaling pathway	5/110	192/8144	0.1179	0.9174	0.9174	CCL8/PIK3R5/PAK1/CCR5/CCL13	5
KEGG	hsa05202	Transcriptional misregulation in cancer	5/110	193/8144	0.1198	0.9174	0.9174	NUPR1/MEIS1/MAX/RXRA/MEF2C	5
KEGG	hsa03022	Basal transcription factors	2/110	45/8144	0.1232	0.9174	0.9174	GTF2E1/TAF13	2
KEGG	hsa04120	Ubiquitin mediated proteolysis	4/110	142/8144	0.1254	0.9174	0.9174	RCHY1/UBE3A/KEAP1/UBR5	4
KEGG	hsa05206	MicroRNAs in cancer	7/110	310/8144	0.1256	0.9174	0.9174	MIR10A/MIR16-2/MIR195/MIR15B/MIR602/MIR128-1/MIR181B1	7
KEGG	hsa03050	Proteasome	2/110	46/8144	0.1277	0.9174	0.9174	PSMB6/PSME4	2
KEGG	hsa05323	Rheumatoid arthritis	3/110	93/8144	0.1308	0.9174	0.9174	ACP5/IL15/ATP6V1H	3
KEGG	hsa05012	Parkinson disease	6/110	266/8144	0.1503	0.9174	0.9174	CALML5/PSMB6/DAXX/KEAP1/NFE2L2/SNCA	6
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	3/110	100/8144	0.1527	0.9174	0.9174	CCL8/CCR5/CCL13	3
KEGG	hsa04150	mTOR signaling pathway	4/110	156/8144	0.1599	0.9174	0.9174	RRAGC/INS/SESN2/ATP6V1H	4
KEGG	hsa05417	Lipid and atherosclerosis	5/110	215/8144	0.1652	0.9174	0.9174	CALML5/MIB1/NFE2L2/RXRA/OLR1	5
KEGG	hsa04625	C-type lectin receptor signaling pathway	3/110	104/8144	0.1657	0.9174	0.9174	CALML5/CLEC6A/PAK1	3
KEGG	hsa04810	Regulation of actin cytoskeleton	5/110	218/8144	0.1719	0.9174	0.9174	SSH1/PAK1/INS/DIAPH1/GNA13	5
KEGG	hsa04923	Regulation of lipolysis in adipocytes	2/110	56/8144	0.1747	0.9174	0.9174	INS/FABP4	2
KEGG	hsa04978	Mineral absorption	2/110	60/8144	0.1942	0.9174	0.9174	SLC34A3/SLC34A1	2
KEGG	hsa05164	Influenza A	4/110	171/8144	0.2001	0.9174	0.9174	TPSB2/NXF1/PABPN1L/TPSAB1	4
KEGG	hsa04010	MAPK signaling pathway	6/110	294/8144	0.2062	0.9174	0.9174	PAK1/DAXX/INS/MAX/NLK/MEF2C	6
KEGG	hsa04071	Sphingolipid signaling pathway	3/110	119/8144	0.2171	0.9174	0.9174	S1PR3/SGPL1/GNA13	3
KEGG	hsa04611	Platelet activation	3/110	124/8144	0.2349	0.9174	0.9174	PIK3R5/GP9/GNA13	3
KEGG	hsa04621	NOD-like receptor signaling pathway	4/110	184/8144	0.2372	0.9174	0.9174	GBP1/GBP5/AIM2/MAP1LC3C	4
KEGG	hsa04920	Adipocytokine signaling pathway	2/110	69/8144	0.2389	0.9174	0.9174	PCK1/RXRA	2
KEGG	hsa05211	Renal cell carcinoma	2/110	69/8144	0.2389	0.9174	0.9174	PAK1/RAPGEF1	2
KEGG	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	2/110	70/8144	0.2439	0.9174	0.9174	PAK1/ATP6V1H	2
KEGG	hsa00770	Pantothenate and CoA biosynthesis	1/110	21/8144	0.2487	0.9174	0.9174	VNN1	1
KEGG	hsa04380	Osteoclast differentiation	3/110	128/8144	0.2493	0.9174	0.9174	ACP5/FCGR2C/LILRB5	3
KEGG	hsa04115	p53 signaling pathway	2/110	73/8144	0.259	0.9174	0.9174	RCHY1/SESN2	2
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	4/110	194/8144	0.2668	0.9174	0.9174	PIK3R5/CALML5/MAP1LC3C/CCR5	4
KEGG	hsa04964	Proximal tubule bicarbonate reclamation	1/110	23/8144	0.2689	0.9174	0.9174	PCK1	1
KEGG	hsa05133	Pertussis	2/110	76/8144	0.2741	0.9174	0.9174	SERPING1/CALML5	2
KEGG	hsa04721	Synaptic vesicle cycle	2/110	78/8144	0.2841	0.9174	0.9174	UNC13A/ATP6V1H	2
KEGG	hsa04140	Autophagy - animal	3/110	141/8144	0.297	0.9174	0.9174	RRAGC/MAP1LC3C/INS	3
KEGG	hsa04950	Maturity onset diabetes of the young	1/110	26/8144	0.2982	0.9174	0.9174	INS	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	3/110	143/8144	0.3044	0.9174	0.9174	KAT6A/SMAD5/MEIS1	3
KEGG	hsa04966	Collecting duct acid secretion	1/110	27/8144	0.3077	0.9174	0.9174	SLC4A1	1
KEGG	hsa04072	Phospholipase D signaling pathway	3/110	148/8144	0.323	0.9174	0.9174	PIK3R5/INS/GNA13	3
KEGG	hsa04392	Hippo signaling pathway - multiple species	1/110	29/8144	0.3264	0.9174	0.9174	PAK1	1
KEGG	hsa00020	Citrate cycle (TCA cycle)	1/110	30/8144	0.3355	0.9174	0.9174	PCK1	1
KEGG	hsa04145	Phagosome	3/110	152/8144	0.3379	0.9174	0.9174	FCGR2C/ATP6V1H/OLR1	3
KEGG	hsa04211	Longevity regulating pathway	2/110	89/8144	0.339	0.9174	0.9174	INS/SESN2	2
KEGG	hsa04151	PI3K-Akt signaling pathway	6/110	354/8144	0.3445	0.9174	0.9174	PIK3R5/CSH2/IL7R/INS/PCK1/RXRA	6
KEGG	hsa04921	Oxytocin signaling pathway	3/110	154/8144	0.3453	0.9174	0.9174	PIK3R5/CALML5/MEF2C	3
KEGG	hsa05222	Small cell lung cancer	2/110	92/8144	0.3538	0.9174	0.9174	MAX/RXRA	2
KEGG	hsa04130	SNARE interactions in vesicular transport	1/110	33/8144	0.3622	0.9174	0.9174	STX11	1
KEGG	hsa05150	Staphylococcus aureus infection	2/110	96/8144	0.3733	0.9174	0.9174	CFB/FCGR2C	2
KEGG	hsa03015	mRNA surveillance pathway	2/110	97/8144	0.3781	0.9174	0.9174	NXF1/PABPN1L	2
KEGG	hsa00564	Glycerophospholipid metabolism	2/110	98/8144	0.383	0.9174	0.9174	PCYT1A/PLA2G15	2
KEGG	hsa04740	Olfactory transduction	7/110	440/8144	0.3841	0.9174	0.9174	CALML5/OR5AR1/OR1D4/OR1D5/OR3A1/OR9A2/OR13C2	7
KEGG	hsa00350	Tyrosine metabolism	1/110	36/8144	0.3878	0.9174	0.9174	DBH	1
KEGG	hsa00760	Nicotinate and nicotinamide metabolism	1/110	36/8144	0.3878	0.9174	0.9174	NT5C2	1
KEGG	hsa04640	Hematopoietic cell lineage	2/110	99/8144	0.3878	0.9174	0.9174	GP9/IL7R	2
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	1/110	37/8144	0.3961	0.9174	0.9174	INS	1
KEGG	hsa05216	Thyroid cancer	1/110	37/8144	0.3961	0.9174	0.9174	RXRA	1
KEGG	hsa05225	Hepatocellular carcinoma	3/110	168/8144	0.397	0.9174	0.9174	KEAP1/NFE2L2/SMARCA2	3
KEGG	hsa05340	Primary immunodeficiency	1/110	38/8144	0.4043	0.9174	0.9174	IL7R	1
KEGG	hsa04974	Protein digestion and absorption	2/110	103/8144	0.4069	0.9174	0.9174	SLC7A8/COL18A1	2
KEGG	hsa04922	Glucagon signaling pathway	2/110	107/8144	0.4257	0.9174	0.9174	CALML5/PCK1	2
KEGG	hsa04216	Ferroptosis	1/110	41/8144	0.4282	0.9174	0.9174	MAP1LC3C	1
KEGG	hsa04931	Insulin resistance	2/110	108/8144	0.4303	0.9174	0.9174	INS/PCK1	2
KEGG	hsa05332	Graft-versus-host disease	1/110	42/8144	0.4359	0.9174	0.9174	KIR2DL3	1
KEGG	hsa05152	Tuberculosis	3/110	180/8144	0.4404	0.9174	0.9174	FCGR2C/CALML5/ATP6V1H	3
KEGG	hsa04940	Type I diabetes mellitus	1/110	43/8144	0.4436	0.9174	0.9174	INS	1
KEGG	hsa04975	Fat digestion and absorption	1/110	43/8144	0.4436	0.9174	0.9174	CLPS	1
KEGG	hsa04360	Axon guidance	3/110	182/8144	0.4475	0.9174	0.9174	SSH1/PAK1/LRRC4	3
KEGG	hsa05145	Toxoplasmosis	2/110	112/8144	0.4488	0.9174	0.9174	PIK3R5/CCR5	2
KEGG	hsa04930	Type II diabetes mellitus	1/110	46/8144	0.466	0.9174	0.9174	INS	1
KEGG	hsa00620	Pyruvate metabolism	1/110	47/8144	0.4732	0.9174	0.9174	PCK1	1
KEGG	hsa04722	Neurotrophin signaling pathway	2/110	119/8144	0.4802	0.9174	0.9174	CALML5/RAPGEF1	2
KEGG	hsa04152	AMPK signaling pathway	2/110	120/8144	0.4846	0.9174	0.9174	INS/PCK1	2
KEGG	hsa00565	Ether lipid metabolism	1/110	49/8144	0.4874	0.9174	0.9174	PLA2G7	1
KEGG	hsa04672	Intestinal immune network for IgA production	1/110	49/8144	0.4874	0.9174	0.9174	IL15	1
KEGG	hsa04919	Thyroid hormone signaling pathway	2/110	121/8144	0.489	0.9174	0.9174	MED13/RXRA	2
KEGG	hsa05110	Vibrio cholerae infection	1/110	50/8144	0.4944	0.9174	0.9174	ATP6V1H	1
KEGG	hsa00330	Arginine and proline metabolism	1/110	51/8144	0.5013	0.9174	0.9174	PRODH2	1
KEGG	hsa04913	Ovarian steroidogenesis	1/110	51/8144	0.5013	0.9174	0.9174	INS	1
KEGG	hsa04510	Focal adhesion	3/110	201/8144	0.5134	0.9174	0.9174	PAK1/RAPGEF1/DIAPH1	3
KEGG	hsa00600	Sphingolipid metabolism	1/110	53/8144	0.5147	0.9174	0.9174	SGPL1	1
KEGG	hsa05203	Viral carcinogenesis	3/110	204/8144	0.5234	0.9174	0.9174	GTF2E1/UBE3A/CCR5	3
KEGG	hsa04114	Oocyte meiosis	2/110	131/8144	0.5314	0.9174	0.9174	CALML5/INS	2
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	2/110	131/8144	0.5314	0.9174	0.9174	PAK1/KIR2DL3	2
KEGG	hsa04015	Rap1 signaling pathway	3/110	210/8144	0.5431	0.9174	0.9174	CALML5/INS/RAPGEF1	3
KEGG	hsa04270	Vascular smooth muscle contraction	2/110	134/8144	0.5437	0.9174	0.9174	CALML5/GNA13	2
KEGG	hsa04080	Neuroactive ligand-receptor interaction	5/110	362/8144	0.5446	0.9174	0.9174	NPY4R/NPS/CSH2/S1PR3/PPY	5
KEGG	hsa00240	Pyrimidine metabolism	1/110	58/8144	0.5468	0.9174	0.9174	NT5C2	1
KEGG	hsa00480	Glutathione metabolism	1/110	58/8144	0.5468	0.9174	0.9174	OPLAH	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	3/110	212/8144	0.5496	0.9174	0.9174	CALML5/PAK1/CCR5	3
KEGG	hsa05014	Amyotrophic lateral sclerosis	5/110	364/8144	0.5496	0.9174	0.9174	PSMB6/NXF1/MAP1LC3C/DNAH3/DAXX	5
KEGG	hsa04730	Long-term depression	1/110	60/8144	0.5591	0.9174	0.9174	GNA13	1
KEGG	hsa04213	Longevity regulating pathway - multiple species	1/110	62/8144	0.571	0.9174	0.9174	INS	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/110	63/8144	0.5769	0.9174	0.9174	CCR5	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/110	63/8144	0.5769	0.9174	0.9174	AIM2	1
KEGG	hsa04024	cAMP signaling pathway	3/110	221/8144	0.578	0.9174	0.9174	CALML5/PAK1/FXYD1	3
KEGG	hsa05163	Human cytomegalovirus infection	3/110	225/8144	0.5903	0.9174	0.9174	CALML5/CCR5/GNA13	3
KEGG	hsa00010	Glycolysis / Gluconeogenesis	1/110	67/8144	0.5994	0.9174	0.9174	PCK1	1
KEGG	hsa04720	Long-term potentiation	1/110	67/8144	0.5994	0.9174	0.9174	CALML5	1
KEGG	hsa04514	Cell adhesion molecules	2/110	149/8144	0.6017	0.9174	0.9174	NCAM2/LRRC4	2
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	2/110	150/8144	0.6054	0.9174	0.9174	PIK3R5/CALML5	2
KEGG	hsa04924	Renin secretion	1/110	69/8144	0.6103	0.9174	0.9174	CALML5	1
KEGG	hsa05031	Amphetamine addiction	1/110	69/8144	0.6103	0.9174	0.9174	CALML5	1
KEGG	hsa04014	Ras signaling pathway	3/110	232/8144	0.6112	0.9174	0.9174	CALML5/PAK1/INS	3
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/110	70/8144	0.6156	0.9174	0.9174	IFNE	1
KEGG	hsa04917	Prolactin signaling pathway	1/110	70/8144	0.6156	0.9174	0.9174	INS	1
KEGG	hsa01240	Biosynthesis of cofactors	2/110	153/8144	0.6162	0.9174	0.9174	IDO1/IDO2	2
KEGG	hsa04520	Adherens junction	1/110	71/8144	0.6208	0.9174	0.9174	NLK	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	2/110	155/8144	0.6233	0.9174	0.9174	INS/RXRA	2
KEGG	hsa04137	Mitophagy - animal	1/110	72/8144	0.626	0.9174	0.9174	MAP1LC3C	1
KEGG	hsa05223	Non-small cell lung cancer	1/110	72/8144	0.626	0.9174	0.9174	RXRA	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	6/110	476/8144	0.6284	0.9174	0.9174	CALML5/PSMB6/MAP1LC3C/DNAH3/DAXX/SNCA	6
KEGG	hsa05214	Glioma	1/110	75/8144	0.6411	0.9174	0.9174	CALML5	1
KEGG	hsa04971	Gastric acid secretion	1/110	76/8144	0.646	0.9174	0.9174	CALML5	1
KEGG	hsa05140	Leishmaniasis	1/110	77/8144	0.6508	0.9174	0.9174	FCGR2C	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/110	77/8144	0.6508	0.9174	0.9174	DSC2	1
KEGG	hsa05131	Shigellosis	3/110	247/8144	0.6536	0.9174	0.9174	RRAGC/MAP1LC3C/DIAPH1	3
KEGG	hsa04612	Antigen processing and presentation	1/110	78/8144	0.6555	0.9174	0.9174	KIR2DL3	1
KEGG	hsa04144	Endocytosis	3/110	251/8144	0.6644	0.9174	0.9174	VTA1/EHD1/CCR5	3
KEGG	hsa04662	B cell receptor signaling pathway	1/110	82/8144	0.674	0.9174	0.9174	LILRB5	1
KEGG	hsa01232	Nucleotide metabolism	1/110	85/8144	0.6871	0.9174	0.9174	NT5C2	1
KEGG	hsa04012	ErbB signaling pathway	1/110	85/8144	0.6871	0.9174	0.9174	PAK1	1
KEGG	hsa04911	Insulin secretion	1/110	86/8144	0.6914	0.9174	0.9174	INS	1
KEGG	hsa04512	ECM-receptor interaction	1/110	88/8144	0.6998	0.9174	0.9174	GP9	1
KEGG	hsa04976	Bile secretion	1/110	89/8144	0.7039	0.9174	0.9174	RXRA	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/110	90/8144	0.7079	0.9174	0.9174	MYBPC3	1
KEGG	hsa04912	GnRH signaling pathway	1/110	93/8144	0.7197	0.9174	0.9174	CALML5	1
KEGG	hsa04970	Salivary secretion	1/110	93/8144	0.7197	0.9174	0.9174	CALML5	1
KEGG	hsa04350	TGF-beta signaling pathway	1/110	94/8144	0.7235	0.9174	0.9174	SMAD5	1
KEGG	hsa05414	Dilated cardiomyopathy	1/110	96/8144	0.731	0.9174	0.9174	MYBPC3	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/110	97/8144	0.7347	0.9174	0.9174	CALML5	1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	1/110	97/8144	0.7347	0.9174	0.9174	PAK1	1
KEGG	hsa04713	Circadian entrainment	1/110	97/8144	0.7347	0.9174	0.9174	CALML5	1
KEGG	hsa05215	Prostate cancer	1/110	97/8144	0.7347	0.9174	0.9174	INS	1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	1/110	98/8144	0.7384	0.9174	0.9174	CALML5	1
KEGG	hsa04925	Aldosterone synthesis and secretion	1/110	98/8144	0.7384	0.9174	0.9174	CALML5	1
KEGG	hsa05231	Choline metabolism in cancer	1/110	98/8144	0.7384	0.9174	0.9174	PCYT1A	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/110	100/8144	0.7455	0.9174	0.9174	DIAPH1	1
KEGG	hsa04916	Melanogenesis	1/110	101/8144	0.7489	0.9174	0.9174	CALML5	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	2/110	197/8144	0.75	0.9174	0.9174	PAK1/GNA13	2
KEGG	hsa04914	Progesterone-mediated oocyte maturation	1/110	102/8144	0.7524	0.9174	0.9174	INS	1
KEGG	hsa04064	NF-kappa B signaling pathway	1/110	104/8144	0.7591	0.9174	0.9174	CCL13	1
KEGG	hsa04660	T cell receptor signaling pathway	1/110	104/8144	0.7591	0.9174	0.9174	PAK1	1
KEGG	hsa05010	Alzheimer disease	4/110	384/8144	0.769	0.9174	0.9174	CALML5/PSMB6/INS/SNCA	4
KEGG	hsa05205	Proteoglycans in cancer	2/110	205/8144	0.7695	0.9174	0.9174	MIR10A/PAK1	2
KEGG	hsa03013	Nucleocytoplasmic transport	1/110	108/8144	0.772	0.9174	0.9174	NXF1	1
KEGG	hsa04659	Th17 cell differentiation	1/110	108/8144	0.772	0.9174	0.9174	RXRA	1
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	1/110	109/8144	0.7751	0.9174	0.9174	NXF1	1
KEGG	hsa04066	HIF-1 signaling pathway	1/110	109/8144	0.7751	0.9174	0.9174	INS	1
KEGG	hsa04668	TNF signaling pathway	1/110	112/8144	0.7842	0.92	0.92	IL15	1
KEGG	hsa04725	Cholinergic synapse	1/110	113/8144	0.7872	0.92	0.92	PIK3R5	1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	1/110	119/8144	0.8041	0.9336	0.9336	CSH2	1
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	2/110	223/8144	0.8088	0.9336	0.9336	KEAP1/NFE2L2	2
KEGG	hsa05171	Coronavirus disease - COVID-19	2/110	232/8144	0.8261	0.9421	0.9421	CFB/RPL3L	2
KEGG	hsa00230	Purine metabolism	1/110	128/8144	0.827	0.9421	0.9421	NT5C2	1
KEGG	hsa04728	Dopaminergic synapse	1/110	132/8144	0.8363	0.9421	0.9421	CALML5	1
KEGG	hsa00190	Oxidative phosphorylation	1/110	134/8144	0.8408	0.9421	0.9421	ATP6V1H	1
KEGG	hsa04210	Apoptosis	1/110	136/8144	0.8451	0.9421	0.9421	DAXX	1
KEGG	hsa04915	Estrogen signaling pathway	1/110	138/8144	0.8493	0.9421	0.9421	CALML5	1
KEGG	hsa05162	Measles	1/110	139/8144	0.8514	0.9421	0.9421	RCHY1	1
KEGG	hsa05017	Spinocerebellar ataxia	1/110	143/8144	0.8594	0.9454	0.9454	PSMB6	1
KEGG	hsa05226	Gastric cancer	1/110	149/8144	0.8706	0.9494	0.9494	RXRA	1
KEGG	hsa04218	Cellular senescence	1/110	156/8144	0.8826	0.9494	0.9494	CALML5	1
KEGG	hsa05160	Hepatitis C	1/110	157/8144	0.8842	0.9494	0.9494	RXRA	1
KEGG	hsa03010	Ribosome	1/110	158/8144	0.8858	0.9494	0.9494	RPL3L	1
KEGG	hsa05020	Prion disease	2/110	273/8144	0.8885	0.9494	0.9494	PSMB6/NCAM2	2
KEGG	hsa04310	Wnt signaling pathway	1/110	167/8144	0.8992	0.9548	0.9548	NLK	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	1/110	171/8144	0.9047	0.9548	0.9548	NFE2L2	1
KEGG	hsa05168	Herpes simplex virus 1 infection	4/110	495/8144	0.9089	0.9548	0.9548	ZNF667/NXF1/DAXX/ZNF316	4
KEGG	hsa05016	Huntington disease	2/110	306/8144	0.923	0.9596	0.9596	PSMB6/DNAH3	2
KEGG	hsa05034	Alcoholism	1/110	187/8144	0.9237	0.9596	0.9596	CALML5	1
KEGG	hsa05415	Diabetic cardiomyopathy	1/110	203/8144	0.9389	0.9668	0.9668	INS	1
KEGG	hsa05165	Human papillomavirus infection	2/110	331/8144	0.9422	0.9668	0.9668	UBE3A/ATP6V1H	2
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	1/110	212/8144	0.9461	0.9668	0.9668	RXRA	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/110	222/8144	0.9532	0.9679	0.9679	IL15	1
KEGG	hsa04714	Thermogenesis	1/110	232/8144	0.9593	0.9679	0.9679	SMARCA2	1
KEGG	hsa04020	Calcium signaling pathway	1/110	240/8144	0.9636	0.9679	0.9679	CALML5	1
KEGG	hsa05132	Salmonella infection	1/110	249/8144	0.9679	0.9679	0.9679	PAK1	1